ReviewBMC pediatrics2026
First neonatal case of primary ciliary dyskinesia caused by a pathogenic DRC1 variant presenting with recurrent atelectasis and airway hypersecretion: a case report and literature review.
Review in BMC pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundPrimary ciliary dyskinesia (PCD) is a relatively rare hereditary disorder. Pathogenic variants in DRC1 are prevalent in East Asian populations and are frequently associated with situs solitus, which often obscures clinical suspicion. More than 80% of affected neonates with PCD present with respiratory distress; however, definitive diagnosis often requires specialized investigations, and many cases remain undiagnosed. Because PCD can progress to chronic obstructive lung disease and bronchiectasis, early diagnosis and appropriate management are essential. We report the first neonatal case of PCD caused by a pathogenic DRC1 variant, in which recurrent atelectasis and airway hypersecretion prompted evaluation and ultimately led to a definitive diagnosis. CASE PRESENTATION : A female infant was born at 37 weeks of gestation via uncomplicated vaginal delivery, with a birth weight of 2,294 g. She had no respiratory distress immediately after birth but developed subcostal retractions and hypoxemia (oxygen saturation around 90%) on day 1 of life (DOL 1). High-flow nasal cannula therapy did not improve her respiratory status. On DOL 3, she developed left upper lobe atelectasis and poor feeding. She was intubated on DOL 4 and transferred to our center for further evaluation. Although she was extubated on DOL 5, right upper lobe atelectasis developed, requiring re-intubation on DOL 6. After a second extubation on DOL 7, she continued to exhibit copious airway secretions and required noninvasive positive-pressure ventilation for an additional 11 days. Contrast-enhanced chest computed tomography, laryngoscopy, bronchoscopy, and upper gastrointestinal contrast studies revealed no structural abnormalities. With continued chest physiotherapy and mucolytic treatment, the right upper lobe atelectasis resolved by DOL 22; however, airway secretions remained excessive. Given the recurrent atelectasis and marked secretions, impaired ciliary function was suspected. High-speed video microscopy on DOL 29 demonstrated ciliary motility abnormalities in nearly all sampled epithelial cells. Genetic testing identified a homozygous deletion of exons 1-4 in the DRC1 gene, confirming the diagnosis of PCD. She continued mucolytic therapy and was discharged from the neonatal intensive care unit on DOL 33.
conclusionsRecurrent atelectasis or airway hypersecretion in neonates should raise suspicion for PCD, even in the absence of situs inversus, and targeted diagnostic evaluation should be pursued.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.